Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in the Subjects With Crohn´s Disease(ALLO-ASC-CD-101)

Trial Profile

Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in the Subjects With Crohn´s Disease(ALLO-ASC-CD-101)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Jun 2017

At a glance

  • Drugs Adipose stem cell therapy Anterogen (Primary)
  • Indications Crohn's disease
  • Focus Adverse reactions
  • Sponsors Anterogen
  • Most Recent Events

    • 15 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top